Chitosan gel containing polymeric nanocapsules: A new formulation for vaginal drug delivery

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 3151-3161

  Frank, Luiza A ^a   Sandri, Giuseppina ^b   D'Autilia, Francesca ^b   Contri, Renata V ^a   Bonferoni, Maria Cristina ^b   Caramella, Carla ^b   Frank, Alejandro G ^a   Pohlmann, Adriana R ^a   Guterres, Silvia S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Eudragit RS 100; Eudragit S 100; Nanotechnology; Vaginal route

Indexed keywords

ANION; CATION; CHITOSAN; DRUG; EUDRAGIT; EUDRAGIT RS; NANOCAPSULE; ACRYLIC ACID RESIN; AGENTS USED INTRAVAGINALLY; METHYLMETHACRYLATE-METHACRYLIC ACID COPOLYMER; NILE RED; OXAZINE DERIVATIVE; POLYMETHACRYLIC ACID DERIVATIVE;

ARTICLE; CONFOCAL LASER MICROSCOPY; DRUG FORMULATION; DRUG PENETRATION; FEMALE; GEL; HYDROPHOBICITY; INTRAVAGINAL DRUG ADMINISTRATION; LIPOPHILICITY; MUCOADHESION; NANOENCAPSULATION; NONHUMAN; PH; SWINE; TENSILE STRENGTH; VAGINA MUCOSA; VISCOSITY; ZETA POTENTIAL; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; METABOLISM; MUCOSA; VAGINA;

ACRYLIC RESINS; ANIMALS; CHITOSAN; FEMALE; MODELS, BIOLOGICAL; MUCOUS MEMBRANE; NANOCAPSULES; OXAZINES; POLYMETHACRYLIC ACIDS; SWINE; VAGINA; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 84903625405     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S62599     Document Type: Article

References (34)

1. Sandri S, Rossi S, Ferrari F, Bonferoni MC, Muzzarelli C, Caramella C. Assessment of chitosan derivatives as buccal and vaginal penetration enhancers. Eur J Pharm Sci. 2004;21:351-359.
2. Valenta C. The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev. 2005;57:1692-1712.
3. Perioli L, Ambrogi V, Venezia L, Pagano C, Ricci M, Rossi C. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels. Colloids Surf B Biointerfaces. 2008;66:141-145.
4. Bonferoni MC, Sandri G, Rossi S, Ferrari F, Gibin S, Caramella C. Chitosan citrate as multifunctional polymer for vaginal delivery Evaluation of penetration enhancement and peptidade inhibition properties. Eur J Pharm Sci. 2008;33:166-176.
5. Baloglu E, Senygit ZA, Karavana SY, Bernkop-Schnürch A. Strategies to prolong the intravaginal residence time of drug delivery systems. J Pharm Pharm Sci. 2009;12:312-336.
6. Bowman MC, Ballard TE, Ackerson CJ, Feldheim DL, Margolis DM, Melander C. Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc. 2008;130:6896-6897.
7. Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, Rodriguez-Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnology. 2010;8:1.
8. Alukda D, Sturgis T, Youan BB. Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention. J Pharm Sci. 2011;100:3345-3356.
9. Patel GM, Patel PV. Novel vaginal anti-HIV drug delivery system of tenofovir disoproxil fumarate. Am J Pharm Tech Res. 2011;1:366-383.
10. Bachhav YG, Patravale VB. Microemulsion-based vaginal gel of clotrimazole: formulation, in vitro evaluation and stability studies. AAPS Pharm Sci Tech. 2009;10:476-481.
11. Schaffazick SR, Guterres SS. Caracterização e estabilidade físicoquímica de sistemas poliméricos nanoparticulados para administração de fármacos. [Physicochemical characterization and stability of the polymeric nanoparticle systems for drug administration]. Quim Nova. 2003;0:1-12. Portuguese.
12. Haas SE, Bettoni CC, de Oliveira LK, Guterres SS, Costa TD. Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium Berghei in vivo. Int J Antimicrob Agents. 2009;34:156-161.
13. Contri RV, Frank LA, Kaiser M, Pohlmann AR, Guterres SS. Decreased irritation of capsaicinoids to human skin by means of nanoencapsulation. Int J Nanomedicine. 2014;9:951.
14. Hussain A, Ahsan F. The vagina as a route for systemic drug delivery. J Control Release. 2005;103:301-313.
15. Illum L, Fischer AN, Jabbal-Gill I, Davis SS. Bioadhesive starch microspheres and absorpition enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Int J Pharm. 2001;222:109-119.
16. Valenta C, Auner BG. The use of polymers for dermal and transdermal delivery. Eur J Pharm Biopharm. 2204;58:279-289.
17. Contri RV, Katzer T, Ourique AF, et al. Combined effect of polymeric nanocapsules and chitosan hydrogel on the increase of capsicinoids adhesion to the skin surface. J Biomed Nanotechnol. 2014;10: 820-830.
18. Rinaudo M. Chitin and chitosan: properties and applications. Prog Polym Sci. 2006;31:603-632.
19. Sayin B, Somavarapu S, Li XW, Sesardic D, Senel S, Alpar OH. TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan nanocomplexes for mucosal delivery of vaccines. Eur J Pharm Sci. 2009;38:362-369.
20. Wittaya-Areekul S, Kruenate J, Prahsarn C. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Int J Pharm. 2006;312: 113-118.
21. Zhang S, Kawakami K. One-step preparation of chitosan solid nanoparticles by electrospray deposition. Int J Pharm. 2010;397: 211-217.
22. Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny R. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm. 2004;57: 19-34.
23. Meng J, Sturgis TF, Youan BB. Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion. Eur J Pharm Sci. 2011;44:57-67.
24. Contri RV, Katzer T, Pohlmann AR, Guterres SS. Chitosan hydrogel containing capsaicinoids-loaded nanocapsules: an innovative formulation for topical delivery. Soft Matter. 2010;8:370-385.
25. Katzer T, Chaves P, Bernardi A, Pohlmann AR, Guterres SS, Beck RC. Castor oil and mineral oil nanoemulsion: development and compatibility with a soft contact lens. Pharm Dev Technol. 2014;19: 232-237.
26. Santos SS, Lorenzoni A, Ferreira LM, et al. Clotrimazole-loaded Eudragit® RS 100 nanocapsules: preparation, characterization and in vitro evaluation of antifungal activity against Candida species. Mater Sci Eng C Mater Biol Appl. 2013;33:1389-1394.
27. Fessi H, Puisilux F, Devissaguet JP, Ammoury N, Benta S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 1989;55:R1-R4.
28. Schaffazick SR, Pohlmann AR, de Cordova CA, Creczynski-Pasa DB, Guterres SS. Protective properties of melatonin-loaded nanoparticles against lipid peroxidation. Int J Pharm. 2005;289:209-213.
29. Bonferoni MC, Rossi S, Ferrari F, Caramella C. A modified Franz diffusion cell for simultaneous assessment of drug release and washability of mucoadhesive gels. Pharm Dev Technol. 1999;4:45-53.
30. Rossi S, Bonferoni MC, Ferrari F, Caramella C. Drug release and washability of mucoadhesive gels based on sodium carboxymethylcellulose and polyacrylic acid. Pharm Dev Technol. 1999;4:55-63.
31. Contri RV, Kaiser M, Poletto FS, Pohlmann AR, Guterres SS. Simultaneous control of capsaicinoids release from polymeric nanocapsules. J Nanosci Nanotechnol. 2011;11:2398-2406.
32. Contri RV, Soares RMD, da Silveira NP, Pohlmann AR, Guterres SS. Develoment of chitosan hydrogels containing nanocapsules and characterization by oscilatory rheology. Proceedings of the XII International Macromolecular Colloquium; September 7-10; 2010; Gramado.
33. Torchilin VP. Drug targeting. Eur J Pharm Sci. 2000;11 Suppl 2: S81-S91.
34. Mallipeddi R, Rohan LC. Nanoparticle-based vaginal drug delivery systems for HIV prevention. Expert Opin Drug Deliv. 2010;7(1):37-48.